Events

Workshop: Semantic Interoperability in Data Spaces
OCT
Tue
01
09:00 - 16:30

This was 1 year ago

Location

Budapest, Hungary

Danubius Hotel Arena
Budapest Ifjúság útja 1-3. 1148
Hungary
Programmes
Digital, Industry & Space AI Continent

This workshop on Semantic Interoperability of Data Spaces is the third one in a row of workshops. It is organised by the International Data Spaces Association, the Big Data Value Association and other partners and will take place the day before the European Big Data Value Forum.

The workshop will focus on

  • discussing different approaches for semantic interoperability in and between data spaces (e.g. ontologies and controlled vocabularies, SHACL shapes, JSON schemas, etc…), and 
  • raising awareness for and discuss cross-domain (semantic) interoperability concepts (e.g. methodologies, vocabularies), and
  • bridging the gap between such concepts, overall and particular in regards to standardisation.

This one-day workshop will be a mix of presentations, interactive parts and discussions.

More information on the target group for this workshop, the content, and the agenda, as well as the possibility to register can be found on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.